Lőrinc Frivaldszky

Dr. Lőrinc Frivaldszky

Bethesda Gyermekkórház, Budapest, Hungary
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2025 in Journal of Psychiatric Research
Verified
Journal Article
Open access
Lőrinc FrivaldszkyLőrinc Frivaldszky
Lőrinc Frivaldszky
KLKincső Lőrincz
Kincső Lőrincz
JHJakub Hoferica
Jakub Hoferica
PHPéter Hegyi
Péter Hegyi
NÁNándor Ács
Nándor Ács
Marton KeszthelyiMarton Keszthelyi
Marton Keszthelyi
Postpartum depression (PPD) is a prevalent and debilitating disorder that occurs in 14% of women after giving birth. We aimed to assess the efficacy and safety of perioperative esketamine for preventing PPD in women undergoing cesarean section. We performed a systematic literature search in five medical databases - MEDLINE, Cochrane Library, Embase, Scopus, and Web of Science on the 12th of January 2025. We searched for trials on the efficacy and safety of esketamine for preventing PPD. We collected data on rates of PPD, Edinburgh Postnatal Depression Scale (EPDS) scores, and adverse effects. Pooled odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. Our systematic search provided 2681 records; we screened 1336 duplicate-free records. A total of 17 eligible studies were identified after title, abstract, and full-text selection. Esketamine administration was associated with a lower rate of PPD at postpartum days 3-7 and 28-42 (OR = 0.43; 95% CI: 0.31-0.59 and OR = 0.59; 95% CI: 0.39-0.87, respectively). Esketamine administration was associated with significantly lower EPDS scores at postpartum days 3-7 (MD = -1.32; 95% CI: 1.84 to -0.80). Our findings suggest that perioperative administration of esketamine was associated with lower PPD rates and lower scores on the EPDS questionnaire and was considered safe compared to placebo/standard care.

9 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OKOrsolya Kiss
Orsolya Kiss
MBMáté Babity
Máté Babity
AKAttila Kovacs
Attila Kovacs
JSJudit Skopal
Judit Skopal
HVHajnalka Vago
Hajnalka Vago
BMBéla Merkely
Béla Merkely
The significance of cardiology screening of referees is not well established. Cardiovascular risk factors and diseases were examined in asymptomatic Hungarian elite handball referees undergoing extended screening: personal/family history, physical examination, 12-lead ECG, laboratory tests, body-composition analysis, echocardiography, and cardiopulmonary exercise testing. Holter-ECG (n = 8), blood pressure monitorization (n = 10), cardiac magnetic resonance imaging (CMR; n = 27) and computer tomography (CCT; n = 4) were also carried out if needed. We examined 100 referees (age: 29.6±7.9years, male: 64, training: 4.3±2.0 hours/week), cardiovascular risk factors were: positive medical history: 24%, overweight: 10%, obesity: 3%, dyslipidaemia: 41%. Elevated resting blood pressure was measured in 38%. Stress-ECG was positive due to ECG-changes in 16%, due to elevated exercise blood pressure in 8%. Echocardiography and/or CMR identified abnormalities in 19%. A significant number of premature ventricular contractions was found on the Holter-ECG in two cases. The CCT showed myocardial bridge or coronary plaques in one-one case. We recommended lifestyle changes in 58%, new/modified antihypertensive or lipid-lowering therapy in 5%, iron-supplementation in 22%. By our results, a high percentage of elite Hungarian handball referees had cardiovascular risk factors or diseases, which, combined with physical and psychological stress, could increase the possibility of cardiovascular events. Our study draws attention to the importance of cardiac screening in elite handball referees.

25 November 2025 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
LDLevente Doleviczényi
Levente Doleviczényi
Lőrinc FrivaldszkyLőrinc Frivaldszky
Lőrinc Frivaldszky
ARAnett Rancz
Anett Rancz
DFDóra Léna Fedorcsák
Dóra Léna Fedorcsák
BSBoglárka Lilla Szentes
Boglárka Lilla Szentes
ZKZoltán Klárik
Zoltán Klárik
Purpose: Seroma formation is one of the most common complications after mastectomy. Seromas can lead to repeated aspirations, increase the risk of infection, and potentially delay oncologic treatment. Several strategies have recently been employed to prevent seromas, but there is no definitive standard. We aim to determine whether perioperative glucocorticoids (GC) are safe and effective in preventing seromas in patients undergoing mastectomy. Methods: We performed a systematic search in five databases on November 12, 2024. Eligible studies included women who underwent mastectomy and received perioperative GCs. Results are reported as risk ratios (RR), odds ratios (OR), or mean differences (MDs) with 95% confidence intervals (CIs), and are presented as forest plots. A random-effects model was used to pool effect sizes. Results: Altogether, 13 studies (12 RCTs and 1 case–control study) with 1011 patients were included; all were eligible for meta-analysis. The rate of seroma formation was significantly lower in the GC groups compared to the placebo groups (RR = 0.56, CI 0.38; 0.82, p = 0,008). Total volume of drainage (MD = -213.36 ml, CI -312.5; -114.22, p = 0.001) and days to drain removal (MD =—3.01 days, CI -4.06; -1.96, p = 0.001) were also lower in the GC groups. The rate of wound infection showed a higher trend in the intervention groups (RR = 1.26, CI 0.82; 1.92, p = 0.224), although the results did not reach statistical significance, Conclusions: Our results suggest that perioperative glucocorticoid administration may reduce seroma formation in patients undergoing mastectomy. A potential increase in wound infection rates was also observed, but this requires further investigation.

18 April 2026 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
BKBegüm Kepkep
Begüm Kepkep
MBMáté Szabolcs Botos
Máté Szabolcs Botos
İYİpek Yazıcı
İpek Yazıcı
Lőrinc FrivaldszkyLőrinc Frivaldszky
Lőrinc Frivaldszky
ARAnett Rancz
Anett Rancz
MPMiklós Sipos PhD
Miklós Sipos PhD
Introduction: Total fertilization failure (TFF) remains a critical barrier in assisted reproductive technology (ART), occurring in 5–10% of treatment cycles. While TFF can result from both male and female gamete factors, emerging evidence suggests that oocyte gene mutations may play a significant role. This study systematically reviews and meta-analyzes the influence of specific oocyte gene mutations (OGMs) on fertilization outcomes, focusing on their association with TFF and fertilization rates (FRs). Methods: This study has a preregistered protocol (CRD42024608566). A comprehensive search was conducted in PubMed, EMBASE, and Cochrane Library on December 10, 2024 and updated on February 5, 2026. Studies involving women undergoing ART with known oocyte gene mutations—including WEE2, PATL2, TUBB8, and others—were evaluated alongside studies of women without identified mutations. TFF and FR were the primary and secondary outcomes, respectively. Data synthesis included pooled proportions with confidence intervals (CIs) using random-effects models. Results: Of the 11,966 records identified, 105 studies were included. A total of 74 studies reported on women with 19 different OGMs, with 31 studies serving as indirect comparators. TFF rates were higher in women with specific mutations including WEE2 , PATL2 , and TUBB8 , when analyzed alongside the indirect comparison patients; which were 66% (95% CI: 44–82%), 67% (95% CI: 50–81%) and 18% (95% CI: 8–38%) respectively. FRs were lower among carriers of these mutations: 3% (95% CI: 1–10%), 2% (95% CI: 0–10%) and 20% (95% CI: 10–38%) respectively. In contrast, the indirect comparator group had a low TFF rate, which was 9% (95% CI: 6%; 14%) and high FR, which was 67% (95% CI: 62%; 71%). Conclusion: Our findings suggest that specific OGMs may be associated with increased TFF rates and decreased FRs in ART. These results highlight the potential clinical value of genetic screening in women with unexplained infertility or repeated ART failures.

1 November 2020 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
OKO Kiss
O Kiss
Lőrinc FrivaldszkyLőrinc Frivaldszky
Lőrinc Frivaldszky
MTM Tokodi
M Tokodi
MBM Babity
M Babity
CBC.S Bognar
C.S Bognar
BMB Merkely
B Merkely
Introduction: Examination of specific cardiac enzymes and peptide fragments is essential in cases of acute myocardial ischemia and heart failure. According to previous data, exhausting physical effort may cause temporary increase of cardiac necroenzyme levels, while no information is available on their resting values in athletes. Methods: Resting serum levels of hsTroponinT, CKMB, LDH and NT-proBNP were measured as part of extended sports cardiology screening in healthy athletes and a healthy sedentary non-athlete control group. Depending on normality, groups were compared with two-tailed Student's t-test or Mann-Whitney U-test. Statistical analysis was processed in RStudio integrated development environment. Results: Results of 237 healthy athletes from different sports (male: 144, age: 19.1±5.9 years, training: 16.0±6.7 hours/week) and 53 sedentary non-athletes (male: 23, age: 19.8±3.2 years, training: 2.6±2.3 hours/week) were analysed. In athletes, increased resting cardiac marker levels were measured as follows: CKMB: 6.3% (n=15), LDH: 3.4% (n=8), hsTroponinT: 4.2% (n=10), NT-proBNP: 0.8% (n=2) of the cases. No elevation of CKMB and hsTroponin T levels were measured in the control group, while only single cases of increased LDH and NT-proBNP were detected. We measured higher levels of CKMB (17.6±7.3 vs. 12.3±3.4 U/l, p<0.001), LDH (322.4±60.8 vs. 286.0±51.1 U/l, p<0.001) and hsTroponinT (6.2±4.7 vs. 4.3±1.4 ng/l, p<0.05), while lower levels of NT-proBNP (23.9±27.2 vs. 49.8±38.7 pg/ml, p<0.001) in athletes compared to the control group. In male athletes, higher levels of CKMB (18.5±6.6 vs. 16.0±8.2 U/l, p<0.001), LDH (337.0±62.2 vs. 300.7±51.9 U/l, p<0.001) and hsTroponinT (7.0±5.3 vs. 4.3±1.9 ng/l, p<0.001), and lower levels of NT-proBNP (19.8±23.1 vs. 35.0±34.1 pg/ml, p<0.001) were measured compared to female athletes. Levels of hsTroponinT decreased in athletes due to increasing age (r=−0.20, p<0.05). Discussion: According to our results, resting levels of cardiac markers show significant alterations due to sport adaptation of the heart. These changes depend on age and sex as well. Conclusions: Our research attract attention to different assessment of cardiac markers in athletes in respect of recognition of cardiovascular pathologies. Funding Acknowledgement: Type of funding source: Public grant(s) – National budget only. Main funding source(s): This project was supported by a grant from the National Research, Development and Innovation Office (NKFIH) of Hungary.

7 February 2026 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
ÁVÁdám Vincze
Ádám Vincze
DMDávid Márai
Dávid Márai
Lőrinc FrivaldszkyLőrinc Frivaldszky
Lőrinc Frivaldszky
ARAnett Rancz
Anett Rancz
PHPéter Hegyi
Péter Hegyi
BLBalázs Lintner
Balázs Lintner
Early-stage cervical cancer tumours ≥2 cm present a dilemma for fertility preservation, as guidelines generally discourage fertility-sparing surgery (FSS) due to oncologic risks. Neoadjuvant chemotherapy (NACT) followed by FSS has emerged as an alternative to downstage tumours. This study evaluated recurrence and pregnancy outcomes of NACT + FSS versus upfront FSS. A PROSPERO-registered (CRD42024605906) meta-analysis was conducted using PubMed, EMBASE, and Cochrane (updated Feb 26, 2025). Eligible studies included women with early-stage cervical cancer (FIGO 2018 IB2-IIA1; ≥2 cm) undergoing upfront FSS or NACT + FSS. Pooled proportions with 95% confidence intervals (CIs) were calculated using a random effects model. Nineteen observational studies (n = 1453) were analysed. Indirect comparison indicated significantly higher pooled pregnancy rate for NACT + FSS (31%; 95% CI: 23-41%) compared to upfront FSS (8%; CI: 1-43%; p = 0.002). Pooled recurrence rate was statistically similar: 10% (CI: 5-20%) for upfront FSS and 13% (CI: 9-20%) for NACT + FSS (p = 0.415). Studies generally exhibited a moderate-to-high risk of bias. NACT followed by FSS appears to enhance fertility outcomes without increasing oncologic risk compared to upfront FSS in patients with tumours ≥2 cm. These findings support the personalized extension of fertility-sparing indications, though prospective validation remains necessary.